About Cell & Gene Therapy USA 2022
With over 20 CGTs projected to be approved by 2025, it’s clear that there are huge commercial and medical opportunities for precision medicine. But despite this unprecedented growth, unstable infrastructure, lack of standardization and novel scientific nuance means that there is still no industry blueprint for successful commercialization.
To realize this potential, precision medicine trailblazers must share lessons of launch success and overcome pain points to allow pharma to reinforce frameworks across manufacturing, market access and reimbursement to build infallible launch strategies across the board. Commercialization networks must go even further, transforming our healthcare system to guarantee scalable and sustainable growth.
When and Where
Event date
Sept 20 - 21, 2022
Event location
United States
Event type
Event fees
Organized by
Reuters Events
Likelihood to recommend event
Reviews
Alexis Hoecheronline | attendee
Process Engineer, cGMPnow
Review Source
Review Source
27th Sep '22
27th Sep '22
Choose your Goal
Select the priority e.g Networking or Learning that closely matches the objectives you would like to meet by attending an event.
Activate Reminder
Sign in or create your free account and click the bell icon to be notified of an upcoming edition for this event.
Receive Alert & Updates
Get timely notifications from Eventible before the start of the next edition. Never miss a must-attend event again!
Explore Upcoming Events
Explore Top Rated Events